25N-NBPh
Chemical compound
| 25N-NBPh | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 123456-78-9 |
| PubChem | 12345678 |
| DrugBank | |
| ChemSpider | 123456 |
| KEGG | |
25N-NBPh is a synthetic psychedelic compound that belongs to the phenethylamine class. It is structurally related to the 2C family of psychedelic phenethylamines, specifically 2C-N, and is part of the NBOMe series of compounds.
Chemical Structure[edit | edit source]
25N-NBPh is characterized by the presence of a piperazine ring, which is substituted with a 2,5-dimethoxyphenethylamine moiety. The compound also features a methoxybenzyl group attached to the nitrogen atom of the piperazine ring. This structural configuration is responsible for its activity as a psychedelic agent.
Pharmacology[edit | edit source]
25N-NBPh acts as a potent agonist at the 5-HT2A receptor, which is the primary target for classical psychedelics. The activation of this receptor is believed to be responsible for the compound's psychedelic effects, which can include alterations in perception, mood, and cognition.
Effects[edit | edit source]
The effects of 25N-NBPh are similar to those of other NBOMe compounds, such as 25I-NBOMe and 25C-NBOMe. Users report visual hallucinations, changes in thought patterns, and an altered sense of time. The intensity and duration of these effects can vary depending on the dose and individual sensitivity.
Safety and Toxicity[edit | edit source]
The safety profile of 25N-NBPh is not well-established, as it is a relatively new compound with limited research. However, compounds in the NBOMe series have been associated with significant risks, including vasoconstriction, hypertension, and seizures. Due to these potential dangers, caution is advised when handling or using this substance.
Legal Status[edit | edit source]
The legal status of 25N-NBPh varies by country. In some jurisdictions, it may be classified as a controlled substance due to its structural similarity to other regulated psychedelics. It is important to consult local laws and regulations before acquiring or using this compound.
Related Compounds[edit | edit source]
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
